Literature DB >> 16907898

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

M W N Harbord1, D J B Marks, A Forbes, S L Bloom, R M Day, A W Segal.   

Abstract

BACKGROUND: Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn's disease. Cantharidin-induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured. AIMS: To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte-colony stimulating factor (G-CSF).
METHODS: Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G-CSF on blister phenotype was determined.
RESULTS: Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase-recruitment domain 15 genotype. G-CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients.
CONCLUSIONS: Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G-CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907898      PMCID: PMC2648502          DOI: 10.1111/j.1365-2036.2006.03016.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  50 in total

1.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

2.  Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.

Authors:  J M Rhodes; B J Potter; D J Brown; D P Jewell
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

3.  Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly.

Authors:  L Harvath; W Falk; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

4.  Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.

Authors:  C O Moráin; A A Segal; D Walker; A J Levi
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

5.  Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease.

Authors:  A W Segal; O T Jones
Journal:  FEBS Lett       Date:  1980-01-28       Impact factor: 4.124

6.  Neutrophil dysfunction in Crohn's disease.

Authors:  A W Segal; G Loewi
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

7.  Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro.

Authors:  J H Wandall; V Binder
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

8.  Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation.

Authors:  Darshna R Yagnik; Betsy J Evans; Oliver Florey; Justin C Mason; R Clive Landis; Dorian O Haskard
Journal:  Arthritis Rheum       Date:  2004-07

9.  Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.

Authors:  Jing Li; Thomas Moran; Eric Swanson; Christina Julian; Jeremy Harris; Denise K Bonen; Matija Hedl; Dan L Nicolae; Clara Abraham; Judy H Cho
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

10.  Human neutrophil Fc gamma receptor distribution and structure.

Authors:  H B Fleit; S D Wright; J C Unkeless
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more
  25 in total

1.  Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.

Authors:  Franco Scaldaferri; Stefania Vetrano
Journal:  Dig Dis Sci       Date:  2015-07       Impact factor: 3.199

Review 2.  Big insights from small volumes: deciphering complex leukocyte behaviors using microfluidics.

Authors:  Daniel Irimia; Felix Ellett
Journal:  J Leukoc Biol       Date:  2016-05-18       Impact factor: 4.962

Review 3.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

4.  Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis.

Authors:  YinHua Tang; YingYing Chen; Xi Wang; Guang Song; YongGuo Li; LiJun Shi
Journal:  Dig Dis Sci       Date:  2015-04-18       Impact factor: 3.199

5.  Validation of the cantharidin-induced skin blister as an in vivo model of inflammation.

Authors:  Phong Huy Duc Dinh; Francis Corraza; Kristel Mestdagh; Zaina Kassengera; Virginie Doyen; Olivier Michel
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 6.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

7.  Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.

Authors:  Jane E Onken; Paula K Greer; Brian Calingaert; Laura P Hale
Journal:  Clin Immunol       Date:  2007-12-21       Impact factor: 3.969

Review 8.  Crohn's disease: an immune deficiency state.

Authors:  Daniel J B Marks; Farooq Z Rahman; Gavin W Sewell; Anthony W Segal
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 9.  What is wrong with granulocytes in inflammatory bowel diseases?

Authors:  Adam P Levine; Anthony W Segal
Journal:  Dig Dis       Date:  2013-11-14       Impact factor: 2.404

10.  New treatment options in the management of IBD - focus on colony stimulating factors.

Authors:  Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.